Literature DB >> 21534727

Progesterone increases circulating endothelial progenitor cells and induces neural regeneration after traumatic brain injury in aged rats.

Zhanying Li1, Bin Wang, Zhisheng Kan, Baoliang Zhang, Zhuo Yang, Jieli Chen, Dong Wang, Huijie Wei, Jian-ning Zhang, Rongcai Jiang.   

Abstract

Vascular remodeling plays a key role in neural regeneration in the injured brain. Circulating endothelial progenitor cells (EPCs) are a mediator of the vascular remodeling process. Previous studies have found that progesterone treatment of traumatic brain injury (TBI) decreases cerebral edema and cellular apoptosis and inhibits inflammation, which in concert promote neuroprotective effects in young adult rats. However, whether progesterone treatment regulates circulating EPC level and fosters vascular remodeling after TBI have not been investigated. In this study, we hypothesize that progesterone treatment following TBI increases circulating EPC levels and promotes vascular remodeling in the injured brain in aged rats. Male Wistar 20-month-old rats were subjected to a moderate unilateral parietal cortical contusion injury and were treated with or without progesterone (n=54/group). Progesterone was administered intraperitoneally at a dose of 16mg/kg at 1 h post-TBI and was subsequently injected subcutaneously daily for 14 days. Neurological functional tests and immnunostaining were performed. Circulating EPCs were measured by flow cytometry. Progesterone treatment significantly improved neurological outcome after TBI measured by the modified neurological severity score, Morris Water Maze and the long term potentiation in the hippocampus as well as increased the circulating EPC levels compared to TBI controls (p<0.05). Progesterone treatment also significantly increased CD34 and CD31 positive cell number and vessel density in the injured brain compared to TBI controls (p<0.05). These data indicate that progesterone treatment of TBI improves multiple neurological functional outcomes, increases the circulating EPC level, and facilitates vascular remodeling in the injured brain after TBI in aged rats.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21534727      PMCID: PMC3261789          DOI: 10.1089/neu.2011.1807

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  82 in total

Review 1.  Progesterone exerts neuroprotective effects after brain injury.

Authors:  Donald G Stein
Journal:  Brain Res Rev       Date:  2007-07-27

Review 2.  Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic.

Authors:  Zheng Gang Zhang; Michael Chopp
Journal:  Lancet Neurol       Date:  2009-05       Impact factor: 44.182

3.  Progesterone and its metabolite allopregnanolone differentially regulate hemostatic proteins after traumatic brain injury.

Authors:  Jacob W VanLandingham; Milos Cekic; Sarah M Cutler; Stuart W Hoffman; Ebony R Washington; Sarah J Johnson; Darren Miller; Donald G Stein
Journal:  J Cereb Blood Flow Metab       Date:  2008-07-16       Impact factor: 6.200

4.  Inhibition of endothelial progenitor cell differentiation by VEGI.

Authors:  Fang Tian; Paulina H Liang; Lu-Yuan Li
Journal:  Blood       Date:  2009-03-27       Impact factor: 22.113

5.  Traditional Chinese drug ShuXueTong facilitates angiogenesis during wound healing following traumatic brain injury.

Authors:  Xiaoying Jin; Gang Shen; Feng Gao; Xuesheng Zheng; Xiaoyan Xu; Fang Shen; Gu Li; Jiangbiao Gong; Liang Wen; Xiaofeng Yang; Xiaodong Bie
Journal:  J Ethnopharmacol       Date:  2008-03-08       Impact factor: 4.360

6.  Endothelial progenitor cell homing: prominent role of the IGF2-IGF2R-PLCbeta2 axis.

Authors:  Yong-Sun Maeng; Hyun-Jung Choi; Ja-Young Kwon; Yong-Won Park; Kyu-Sil Choi; Jeong-Ki Min; Yun-Hee Kim; Pann-Ghill Suh; Kyung-Sun Kang; Moo-Ho Won; Young-Myeong Kim; Young-Guen Kwon
Journal:  Blood       Date:  2008-10-02       Impact factor: 22.113

7.  Prolonged use of high-dose morphine impairs angiogenesis and mobilization of endothelial progenitor cells in mice.

Authors:  Chen-Fuh Lam; Pei-Jung Chang; Yu-Sheng Huang; Yen-Hui Sung; Chien-Chi Huang; Ming-Wei Lin; Yen-Chin Liu; Yu-Chuan Tsai
Journal:  Anesth Analg       Date:  2008-08       Impact factor: 5.108

8.  Delayed transplantation of human marrow stromal cell-seeded scaffolds increases transcallosal neural fiber length, angiogenesis, and hippocampal neuronal survival and improves functional outcome after traumatic brain injury in rats.

Authors:  Ye Xiong; Changsheng Qu; Asim Mahmood; Zhongwu Liu; Ruizhuo Ning; Yi Li; David L Kaplan; Timothy Schallert; Michael Chopp
Journal:  Brain Res       Date:  2009-01-30       Impact factor: 3.252

Review 9.  Emerging treatments for traumatic brain injury.

Authors:  Ye Xiong; Asim Mahmood; Michael Chopp
Journal:  Expert Opin Emerg Drugs       Date:  2009-03       Impact factor: 4.191

Review 10.  Pathophysiology of traumatic brain injury.

Authors:  Mark W Greve; Brian J Zink
Journal:  Mt Sinai J Med       Date:  2009-04
View more
  35 in total

1.  Progesterone increases the release of brain-derived neurotrophic factor from glia via progesterone receptor membrane component 1 (Pgrmc1)-dependent ERK5 signaling.

Authors:  Chang Su; Rebecca L Cunningham; Nataliya Rybalchenko; Meharvan Singh
Journal:  Endocrinology       Date:  2012-07-09       Impact factor: 4.736

Review 2.  Progesterone for neuroprotection in pediatric traumatic brain injury.

Authors:  Courtney L Robertson; Emin Fidan; Rachel M Stanley; Corina Noje; Hülya Bayir
Journal:  Pediatr Crit Care Med       Date:  2015-03       Impact factor: 3.624

3.  Progesterone-mediated angiogenic activity of endothelial progenitor cell and angiogenesis in traumatic brain injury rats were antagonized by progesterone receptor antagonist.

Authors:  Peng Yu; Shengjie Li; Zhifei Zhang; Xiaolong Wen; Wei Quan; Qilong Tian; Chuang Gao; Wanqiang Su; Jianning Zhang; Rongcai Jiang
Journal:  Cell Prolif       Date:  2017-07-28       Impact factor: 6.831

4.  Intracerebroventricular transplantation of ex vivo expanded endothelial colony-forming cells restores blood-brain barrier integrity and promotes angiogenesis of mice with traumatic brain injury.

Authors:  Xin-Tao Huang; Yong-Qiang Zhang; Sheng-Jie Li; Sheng-Hui Li; Qing Tang; Zhi-Tao Wang; Jing-Fei Dong; Jian-Ning Zhang
Journal:  J Neurotrauma       Date:  2013-11-21       Impact factor: 5.269

5.  Models of Traumatic Brain Injury in Aged Animals: A Clinical Perspective.

Authors:  Aiwane Iboaya; Janna L Harris; Alexandra Nielsen Arickx; Randolph J Nudo
Journal:  Neurorehabil Neural Repair       Date:  2019-11-13       Impact factor: 3.919

Review 6.  The great migration of bone marrow-derived stem cells toward the ischemic brain: therapeutic implications for stroke and other neurological disorders.

Authors:  Cesar V Borlongan; Loren E Glover; Naoki Tajiri; Yuji Kaneko; Thomas B Freeman
Journal:  Prog Neurobiol       Date:  2011-08-30       Impact factor: 11.685

Review 7.  Sex-related responses after traumatic brain injury: Considerations for preclinical modeling.

Authors:  Claudia B Späni; David J Braun; Linda J Van Eldik
Journal:  Front Neuroendocrinol       Date:  2018-05-18       Impact factor: 8.606

8.  Progesterone Changes VEGF and BDNF Expression and Promotes Neurogenesis After Ischemic Stroke.

Authors:  Chao Jiang; Fangfang Zuo; Yuejuan Wang; Hong Lu; Qingwu Yang; Jian Wang
Journal:  Mol Neurobiol       Date:  2016-01-08       Impact factor: 5.590

9.  Recombinant human erythropoietin improves the neurofunctional recovery of rats following traumatic brain injury via an increase in circulating endothelial progenitor cells.

Authors:  Liang Wang; Xiaonan Wang; Hua Su; Zhenying Han; Huijie Yu; Dong Wang; Rongcai Jiang; Zhenlin Liu; Jianning Zhang
Journal:  Transl Stroke Res       Date:  2014-08-03       Impact factor: 6.829

10.  Effects of Mild Hypothermia Treatment on Rat Hippocampal β-Amyloid Expression Following Traumatic Brain Injury.

Authors:  Shi-Xiang Cheng; Sai Zhang; Hong-Tao Sun; Yue Tu
Journal:  Ther Hypothermia Temp Manag       Date:  2013-09       Impact factor: 1.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.